JMP puts Medtronic at strong buy

Medtronic, Inc. was given a strong buy rating by JMP Securities analyst Robert C. Faulkner. JMP said that while the ICD business is central to the company's growth, the business as a whole appears able to support 15% earnings-per-share growth through 2007 even under a slow-ICD scenario and more easily thereafter. Cash flow and cash offer sources of growth that make 15% look obtainable. JMP's 2006 earnings-per-share estimate is $2.23, with its 2007 estimate lowered to $2.55 from $2.57. Shares of the Minneapolis medical appliances company were down $1.27, or 2.29%, at $54.30 on volume of 8,443,700 shares versus the three-month running average of 3,523,540 shares. (NYSE: MDT)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.